(Q35538245)

English

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

scientific article published on 10 March 2015

Statements

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study (English)
Grisell Ortiz-Lasanta
Mordechai Rabinovitz
Natarajan Ravendhran
Delphine Hennicken

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit